• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

PMD Updates on the Reverse Share Split Following the Reverse Acquisition

Share:

January 23, 2024

PMD, formerly Promore Pharma AB, has completed a reverse acquisition with the PMD group, simultaneously deciding on a 1:128 reverse share split. The extraordinary general meeting authorized the board to determine the record date for the reverse split, expected to be resolved in January. PMD develops and sells medical products for respiratory monitoring, with its primary product being RespiraSense™. The company aims to increase its market share in the UK and expand into Germany and the US. PMD is listed on Nasdaq First North Growth Market.

PMD or the “Company” formerly Promore Pharma AB, carried out the reverse acquisition with the PMD group by decision of the extraordinary general meeting on 29 December 2023 and simultaneously decided on a reverse share split (1:128).

The extraordinary general meeting authorised the board of directors to determine the record date for the reverse split which is expected to be resolved upon during the month of January. The Board will, in connection with the determination of the record date for the reverse split, publish further information on the procedure for the reverse split.

Information about PMD

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

PMD develops and sells medical products for respiratory monitoring. Its primary product is RespiraSense™, a solution used for monitoring respiratory rate to detect deterioration of a patient’s general condition early and to avoid preventable respiratory failure and adverse patient outcomes. RespiraSense™ is, to the PMD’s knowledge, the world’s only continuous, motion-tolerant respiratory rate monitor delivering class-leading reliability in measuring respiratory rate. PMD received FDA approval for RespiraSense™ in 2022. RespiraSense™ is a novel technology and today used in 25 hospitals across United Kingdom and Ireland. PMD seeks to continue increasing its market share in the United Kingdom, with Germany and the United States to follow with initial market access activities. The Company is listed on Nasdaq First North Growth Market.

Source: Bio Space

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Takeda Could Sell Some Shire Assets to Pay Down Deal DebtTakeda Could Sell Some Shire Assets to Pay Down Deal Debt
  • Livongo will work with Apple Watch and other wearables to nudge you into healthy habitsLivongo will work with Apple Watch and other wearables to nudge you into healthy habits
  • Zogenix Buys Modis in $400 Million-Plus Deal to Make Larger Rare Disease CompanyZogenix Buys Modis in $400 Million-Plus Deal to Make Larger Rare Disease Company
  • Stryker acquires N.C. med device firm for $220 millionStryker acquires N.C. med device firm for $220 million
  • Boston Children’s Hospital Taps Kyruus to Power Digital Access InitiativesBoston Children’s Hospital Taps Kyruus to Power Digital Access Initiatives
  • How Data Silos Are Ruining the Modern Healthcare IndustryHow Data Silos Are Ruining the Modern Healthcare Industry
  • Veracyte to Acquire Decipher BiosciencesVeracyte to Acquire Decipher Biosciences
  • PurMinds Acquires Novel Chemical Entity HDAC6 Inhibitor for Neurological DisordersPurMinds Acquires Novel Chemical Entity HDAC6 Inhibitor for Neurological Disorders

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications